Thomas A. Waldmann
Impact in
- Immunology top 0.01%
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- T-cell and Retrovirus Studies
- Immune Cell Function and Interaction
- Oncology top 0.1%
- Cytokine Signaling Pathways and Interactions
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 335
- T-cell and B-cell Immunology 153
- T-cell and Retrovirus Studies 92
- Immunodeficiency and Autoimmune Disorders 50
- Immune Cell Function and Interaction 32
-
- Monoclonal and Polyclonal Antibodies Research 61
- Radiopharmaceutical Chemistry and Applications 38
- Co-authors
- Yutaka Tagaya (27 shared papers)Stanley J. Korsmeyer (22 shared papers)Warren Strober (40 shared papers)Warner C. Greene (28 shared papers)S Broder (10 shared papers)Warren J. Leonard (18 shared papers)Takashi Uchiyama (3 shared papers)Sigrid P. Dubois (27 shared papers)
- Journals
- Proceedings of the National Academy of Sciences (72 papers)Blood (49 papers)The Journal of Immunology (49 papers)Journal of Clinical Investigation (28 papers)New England Journal of Medicine (19 papers)
- Partner nations
- United StatesJapanGermany
In The Last Decade
Thomas A. Waldmann
604 papers receiving 48.8k citations
Thomas A. Waldmann's Hit Papers
Peers
Comparison fields: 5 of 159
- Immunology 20.9k
- Oncology 9.1k
- Virology 1.4k
- Pathology and Forensic Medicine 4.9k
- Radiology, Nuclear Medicine and Imaging 5k
Countries citing papers authored by Thomas A. Waldmann
This map shows the geographic impact of Thomas A. Waldmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Waldmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Waldmann more than expected).
Fields of papers citing papers by Thomas A. Waldmann
This network shows the impact of papers produced by Thomas A. Waldmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Waldmann. The network helps show where Thomas A. Waldmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas A. Waldmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 614 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. Hit paper breakdown → | 1981 | 1206 |
| 2 | The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design Hit paper breakdown → | 2006 | 994 |
| 3 | Structure of the human immunoglobulin μ locus: Characterization of embryonic and rearranged J and D genes Hit paper breakdown → | 1981 | 876 |
| 4 | 2005 | 828 | |
| 5 | A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor Hit paper breakdown → | 1982 | 776 |
| 6 | Molecular cloning and expression of cDNAs for the human interleukin-2 receptor Hit paper breakdown → | 1984 | 774 |
| 7 | 2002 | 773 | |
| 8 | Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics Hit paper breakdown → | 2012 | 708 |
| 9 | ROLE OF SUPPRESSOR T CELLS IN PATHOGENESIS OF COMMON VARIABLE HYPOGAMMAGLOBULINÆMIA Hit paper breakdown → | 1974 | 644 |
| 10 | 1985 | 644 | |
| 11 | 1999 | 627 | |
| 12 | Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer Hit paper breakdown → | 2014 | 606 |
| 13 | A humanized antibody that binds to the interleukin 2 receptor. Hit paper breakdown → | 1989 | 548 |
| 14 | Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription. Hit paper breakdown → | 1984 | 544 |
| 15 | Immunoglobulin-Gene Rearrangements as Unique Clonal Markers in Human Lymphoid Neoplasms Hit paper breakdown → | 1983 | 537 |
| 16 | Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphocytic leukemias of T cell and B cell precursor origins. Hit paper breakdown → | 1983 | 520 |
| 17 | 2004 | 508 | |
| 18 | 2006 | 496 | |
| 19 | 2003 | 493 | |
| 20 | Developmental hierarchy of immunoglobulin gene rearrangements in human leukemic pre-B-cells. Hit paper breakdown → | 1981 | 489 |
About Thomas A. Waldmann
Thomas A. Waldmann is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging, Oncology, Pathology and Forensic Medicine and Hematology, having authored 614 papers that have together received 53.8k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (153 papers), T-cell and Retrovirus Studies (92 papers), Cytokine Signaling Pathways and Interactions (67 papers), Monoclonal and Polyclonal Antibodies Research (61 papers), Immunodeficiency and Autoimmune Disorders (50 papers), Lymphoma Diagnosis and Treatment (41 papers), Radiopharmaceutical Chemistry and Applications (38 papers) and Immune Cell Function and Interaction (32 papers). The work is most often cited by research in Immunology (20.9k citations), Oncology (9.1k citations), Virology (1.4k citations), Pathology and Forensic Medicine (4.9k citations) and Radiology, Nuclear Medicine and Imaging (5k citations). Thomas A. Waldmann has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include Yutaka Tagaya, Stanley J. Korsmeyer, Warren Strober, Warner C. Greene, S Broder, Warren J. Leonard, Takashi Uchiyama, Sigrid P. Dubois, Philip Leder and Jeffrey V. Ravetch. Their work appears in journals such as Proceedings of the National Academy of Sciences, Blood, The Journal of Immunology, Journal of Clinical Investigation and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.